Autism Spectrum Disorder (ASD) and Intellectual Disability (ID) Determinants in Tuberous Sclerosis Complex (TSC)
Sponsor: Boston Children's Hospital
A observational or N/A phase clinical study on Autism Disorder and Intellectual Disability, this trial is ongoing. The trial is conducted by Boston Children's Hospital and has accumulated 20 data snapshots since 2015. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
20 versions recorded-
Nov 2024 — Present [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Dec 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Dec 2023 [monthly]
Recruiting
▶ Show 15 earlier versions
-
Dec 2021 — Sep 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Recruiting
-
May 2020 — Sep 2020 [monthly]
Recruiting
Status: Active Not Recruiting → Recruiting
-
Feb 2020 — May 2020 [monthly]
Active Not Recruiting
-
Jul 2019 — Feb 2020 [monthly]
Active Not Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Active Not Recruiting
-
Nov 2018 — Apr 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2017 — Aug 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Children's Hospital
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- National Center for Advancing Translational Sciences (NCATS)
- National Institute of Neurological Disorders and Stroke (NINDS)
- National Institutes of Health (NIH)
- Office of Rare Diseases (ORD)
- Tuberous Sclerosis Alliance
For direct contact, visit the study record on ClinicalTrials.gov .